StockData
Hyperfine, Inc. logo

Hyperfine, Inc. (HYPR) stock

HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3028% below fair value
$0.55+0.02 (+4.27%)

Close on Nov 20, 2026Market cap $57.96MP/E –Yield –

Hyperfine gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Hyperfine's gross profit for the twelve months ending Jun 30, 2026 was $8.50M, up 71.9% year over year. For fiscal 2025 it was $6.75M, up 14.6% from the year before. The highest annual figure on record is $6.75M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.75M+14.6%
FY2024Dec 31, 2024$5.89M+23.8%
FY2023Dec 31, 2023$4.76M+424.5%
FY2022Dec 31, 2022$907.00K–
FY2021Dec 31, 2021-$1.17M–
FY2020Dec 31, 2020-$477.00K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.98M+49.1%
Q1 FY2026Mar 31, 2026$1.98M+124.1%
Q4 FY2025Dec 31, 2025$2.69M+226.2%
Q3 FY2025Sep 30, 2025$1.85M-3.1%
Q2 FY2025Jun 30, 2025$1.33M-26.3%
Q1 FY2025Mar 31, 2025$883.00K-34.8%
Q4 FY2024Dec 31, 2024$826.00K-20.1%
Q3 FY2024Sep 30, 2024$1.91M+69.8%
Q2 FY2024Jun 30, 2024$1.80M+24.9%
Q1 FY2024Mar 31, 2024$1.35M+17.2%
Q4 FY2023Dec 31, 2023$1.03M+244.7%
Q3 FY2023Sep 30, 2023$1.12M+63.4%
Q2 FY2023Jun 30, 2023$1.44M–
Q1 FY2023Mar 31, 2023$1.16M+1275.0%
Q4 FY2022Dec 31, 2022$300.00K–
Q3 FY2022Sep 30, 2022$688.00K–
Q2 FY2022Jun 30, 2022-$165.00K–
Q1 FY2022Mar 31, 2022$84.00K–
Q4 FY2021Dec 31, 2021-$453.00K–
Q3 FY2021Sep 30, 2021-$338.00K–
Q2 FY2021Jun 30, 2021-$99.00K–
Q1 FY2021Mar 31, 2021-$277.00K–

More Hyperfine figures

See a number that looks wrong?